Vendor, Pullman, WA
Hexamer Therapeutics Inc.
UEI MK8HSFMVB647, CAGE 9CUB9
1 award and $0 obligated between March 27, 2025 and June 3, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HT942523C0078Definitive Contract, March 27, 2025, Full and Open Competition, 1 offers | Army Med Res Acq ActivityDefense Health Agency | Peptide Based, Self-Assembling, Molecular Carrier (Scaffold) Vaccine Platform Ideal for Deployment During an Infectious Disease Pandemic by NAICS 541714, PSC AN11 | $0 |
- Places of performance
- Washington
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 4 across 1 awards